These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33196)

  • 1. High-performance liquid chromatographic determination of aminosalicylate, sulfapyridine and their metabolites. Its application for pharmacokinetic studies with salicylazosulfapyridine in man.
    Fischer C; Klotz U
    J Chromatogr; 1979 Feb; 162(2):237-43. PubMed ID: 33196
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of sulfapyridine and its major metabolites in plasma by high pressure liquid chromatography.
    Fischer C; Klotz U
    J Chromatogr; 1978 Jul; 146(1):157-62. PubMed ID: 27529
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between the acetylator phenotype, plasma sulfapyridine levels and adverse effects during treatment with salicylazosulfapyridine in patients with chronic bowel diseases.
    Rahav G; Zylber-Katz E; Rachmilewitz D; Levy M
    Isr J Med Sci; 1990 Jan; 26(1):31-4. PubMed ID: 1968894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of salicylazosulphapyridine and sulphapyridine in plasma using high-performance liquid chromatography.
    Lanbeck K; Lindström B
    J Chromatogr; 1978 Jul; 154(2):321-4. PubMed ID: 28333
    [No Abstract]   [Full Text] [Related]  

  • 5. A rapid method for the simultaneous determination of the major metabolites of sulphasalazine in plasma.
    Shaw PN; Sivner AL; Aarons L; Houston JB
    J Chromatogr; 1983 May; 274():393-7. PubMed ID: 6135701
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of the intestinal flora in the acetylation of sulfasalazine metabolites.
    Dull BJ; Salata K; Goldman P
    Biochem Pharmacol; 1987 Nov; 36(21):3772-4. PubMed ID: 2890356
    [No Abstract]   [Full Text] [Related]  

  • 7. Sulfapyridine appearance in plasma after salicylazosulfapyridine. Another simple measure of intestinal transit.
    Kellow JE; Borody TJ; Phillips SF; Haddad AC; Brown ML
    Gastroenterology; 1986 Aug; 91(2):396-400. PubMed ID: 2873075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estimations of the serum levels of sulfapyridine on patients treated with sulfasalazin (author's transl)].
    Eitner K; Hippius M; Reinicke C
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(1):14-9. PubMed ID: 6122556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylator phenotype and serum levels of sulfapyridine in patients with inflammatory bowel disease.
    Sharp ME; Wallace SM; Hindmarsh KW; Brown MA
    Eur J Clin Pharmacol; 1981; 21(3):243-50. PubMed ID: 6119205
    [No Abstract]   [Full Text] [Related]  

  • 10. High-performance liquid chromatographic assay of sulfapyridine and acetylsulfapyridine in biological fluids.
    Owerbach J; Johnson NF; Bates TR; Pieniaszek HJ; Jusko WJ
    J Pharm Sci; 1978 Sep; 67(9):1250-3. PubMed ID: 690830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of rifampicin on sulphapyridine plasma concentrations following sulphasalazine administration.
    Shaffer JL; Houston JB
    Br J Clin Pharmacol; 1985 Apr; 19(4):526-8. PubMed ID: 2859874
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease.
    Das KM; Eastwood MA
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):514-20. PubMed ID: 241531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of sulfasalazine and its metabolites sulfapyridine and N-acetylsulfapyridine in human serum by ion-pair high-performance liquid chromatography using a polymer-based column.
    Buggé CJ; Gautam SR; Parke LE; Mason JT; Garcia DB
    J Pharm Sci; 1990 Dec; 79(12):1095-8. PubMed ID: 1981912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.
    Das KM; Eastwood MA; McManus JP; Sircus W
    N Engl J Med; 1973 Sep; 289(10):491-5. PubMed ID: 4146729
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulfapyridine metabolites in children with inflammatory bowel disease receiving sulfasalazine.
    Goldstein PD; Alpers DH; Keating JP
    J Pediatr; 1979 Oct; 95(4):638-40. PubMed ID: 39125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of sulphapyridine and its N4-acetyl metabolite in plasma using liquid chromatography.
    Lanbeck K; Lindström B
    J Chromatogr; 1979 Jul; 174(2):490-1. PubMed ID: 546903
    [No Abstract]   [Full Text] [Related]  

  • 17. Rapid method for the determination of either plasma sulphapyridine or sulphamethoxazole and their acetyl metabolites using high-performance liquid chromatography.
    Astbury C; Dixon JS
    J Chromatogr; 1987 Feb; 414(1):223-7. PubMed ID: 3494739
    [No Abstract]   [Full Text] [Related]  

  • 18. Salivary excretion and pharmacokinetics of sulfapyridine after sulfasalazine.
    Bates TR; Blumenthal HP; Pieniaszek HJ
    Clin Pharmacol Ther; 1977 Dec; 22(6):917-27. PubMed ID: 21768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous formation of immunogenic conjugates by 5-aminosalicylic acid--a biotransformation product of salicylazosulfapyridine.
    Cîrstea M; Suhaciu G; Cîrje M
    Physiologie; 1983; 20(3):161-7. PubMed ID: 6139832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic method with electrochemical detection for the concomitant assay of sulphadiazine, sulphamerazine and sulphapyridine in plasma.
    Mallett DN; Gulaid AA; Dennis MJ
    J Chromatogr; 1988 Jun; 428(1):190-5. PubMed ID: 3170674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.